Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives.

Journal of the American Society of Nephrology : JASN
P A SingerD C Mendelssohn

Abstract

The purpose of this study was to describe the life-sustaining treatment preferences of dialysis patients and to compare the acceptability of two generic and a disease-specific advance directive (AD). Of 532 potentially eligible hemodialysis patients, 95 (17.9%) participated in the study. These patients completed two generic (the Centre for Bioethics Living Will and the Medical Directive) and one disease-specific (the Dialysis Living Will) AD in a randomized cross-over trial. Treatment preferences were measured by using the Centre for Bioethics Living Will. Acceptability of the AD was measured by using a 13-item advance directive acceptability questionnaire (ADAQ) for each AD, and the advance directive choice questionnaire (ADCQ) to elicit participants' preferred AD. Twenty-five percent of the participants wanted to continue dialysis in case of severe stroke, 19% in severe dementia, and 14% in permanent coma. Averaged across treatments, proportions of participants wanting treatment in various health states were: current health (86%), mild stroke (84%), moderate stroke (60%), severe stroke (21%), mild dementia (78%), moderate dementia (51%), severe dementia (14%), terminal illness (41%), and permanent coma (10%). Averaged across ...Continue Reading

Citations

Jan 22, 1998·Journal of General Internal Medicine·P A SingerC D Naylor
Nov 23, 2000·Lancet·D K MartinP A Singer
Oct 7, 2009·International Journal of Aging & Human Development·Rachel PruchnoMaureen Wilson-Genderson
Jan 22, 2003·Seminars in Dialysis·Fadi Hijazi, Jean L Holley
Aug 25, 2020·JAMA Network Open·Gwen M BernackiAnn M O'Hare
May 14, 2004·Journal of Advanced Nursing·Amy Olivier Calvin
Apr 30, 2005·Journal of Palliative Medicine·A T MoniasD E Meier
Jun 27, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·John E AndersonThomas E Finucane
Mar 10, 2006·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Rachel A PruchnoNorman G Levinsky
Dec 26, 2006·Resuscitation·Annette V M AlfonzoJonathan Fox
Dec 23, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Sara N Davison, Colleen Torgunrud
Dec 23, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Joline L T ChenRobert Goldberg
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·W D SmuckerK M Coppola
Sep 9, 2015·Journal of Comparative Effectiveness Research·Rebecca A AslaksonJohn F P Bridges
Apr 9, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J L HolleyA H Moss
Sep 18, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J L HolleyR Rault
Apr 1, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Alvin H Moss
Oct 17, 2006·Palliative & Supportive Care·Karen M KnopsFredrick J Meyers
Oct 25, 2013·Current Opinion in Supportive and Palliative Care·Marisa del V PérezAlejo F Agranatti
Sep 8, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Manjula Kurella TamuraEliseo J Pérez-Stable
Oct 8, 2009·Clinical Journal of the American Society of Nephrology : CJASN·Rachel C CarsonAine Burns
Jul 28, 2016·The Cochrane Database of Systematic Reviews·Chi Eung Danforn LimFrank Brennan
May 24, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael J GermainAlvin H Moss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
J L HolleyR Rault
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
M ShankarR A Kadir
© 2021 Meta ULC. All rights reserved